BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fowkes FG, Aboyans V, Fowkes FJ, McDermott MM, Sampson UK, Criqui MH. Peripheral artery disease: epidemiology and global perspectives. Nat Rev Cardiol. 2017;14:156-170. [PMID: 27853158 DOI: 10.1038/nrcardio.2016.179] [Cited by in Crossref: 216] [Cited by in F6Publishing: 185] [Article Influence: 36.0] [Reference Citation Analysis]
Number Citing Articles
1 Onoyama A, Hoshiyama M, Yabe H. Relationship Between Psychological Factors and Wound Occurrence in Patients With Peripheral Arterial Disease in the Leg. Int J Low Extrem Wounds 2020;:1534734620943813. [PMID: 32806973 DOI: 10.1177/1534734620943813] [Reference Citation Analysis]
2 Feijão T, Torres AL, Araújo M, Barrias CC. Peptide-Modified Hydrogels for Therapeutic Vascularization. Biomedical Applications of Functionalized Nanomaterials. Elsevier; 2018. pp. 599-620. [DOI: 10.1016/b978-0-323-50878-0.00020-3] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Semenza GL. Hypoxia-inducible factors: roles in cardiovascular disease progression, prevention, and treatment. Cardiovasc Res 2022:cvac089. [PMID: 35687650 DOI: 10.1093/cvr/cvac089] [Reference Citation Analysis]
4 Kulezic A, Bergwall S, Fatemi S, Sonestedt E, Zarrouk M, Gottsäter A, Acosta S. Healthy diet and fiber intake are associated with decreased risk of incident symptomatic peripheral artery disease – A prospective cohort study. Vasc Med 2019;24:511-8. [DOI: 10.1177/1358863x19867393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
5 Farber A. VOYAGER PAD contributes to medical therapy for peripheral artery disease. J Vasc Surg 2020;72:1843-4. [PMID: 33222822 DOI: 10.1016/j.jvs.2020.06.101] [Reference Citation Analysis]
6 Dong Q, Tian J, Zheng W, Fan Q, Wu X, Tang Y, Liu T, Yin H. Interleukin-33 protects mice against hindlimb ischemic injury by enhancing endothelial angiogenesis. International Immunopharmacology 2022;109:108850. [DOI: 10.1016/j.intimp.2022.108850] [Reference Citation Analysis]
7 Zhang J, Rao G, Qiu J, He R, Wang Q. MicroRNA-210 improves perfusion recovery following hindlimb ischemia via suppressing reactive oxygen species. Exp Ther Med 2020;20:236. [PMID: 33149789 DOI: 10.3892/etm.2020.9366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ziegler L, Hedin U, Gottsäter A. Circulating Biomarkers in Lower Extremity Artery Disease. Eur Cardiol 2022;17:e09. [DOI: 10.15420/ecr.2021.58] [Reference Citation Analysis]
9 Li C, Xia P, He Y, Zhou H, Zhao B, Zhang D. Two mixed-ligand coordination polymers: selective detection of acac and treatment activity on peripheral artery disease by reducing the peptidyl arginine deiminase activity. Journal of Molecular Structure 2021;1229:129613. [DOI: 10.1016/j.molstruc.2020.129613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Celebi S, Ozcan Celebi O, Çetin S, Cetin EHO, Diker E, Aydogdu S, Berkalp B, Amasyalı B. Invasive screening for lower extremity peripheral artery disease: Killing two birds with one stone? Vascular 2020;28:196-202. [PMID: 31604386 DOI: 10.1177/1708538119881592] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Blais C, Rochette L, Ouellet S, Huynh T. Complex Evolution of Epidemiology of Vascular Diseases, Including Increased Disease Burden: From 2000 to 2015. Can J Cardiol 2020;36:740-6. [PMID: 32146067 DOI: 10.1016/j.cjca.2019.10.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Deng J, Liu J, Rong D, Ge Y, Li H, Jia S, Sun G, Zhang H, Liu X, Guo W. Association between Cystatin C and Peripheral Artery Disease in the Chinese Han Population. Ann Vasc Surg 2021;73:244-53. [PMID: 33388409 DOI: 10.1016/j.avsg.2020.11.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kolossváry E, Ferenci T, Kováts T. Potentials, challenges, and limitations of the analysis of administrative data on vascular limb amputations in health care. Vasa 2020;49:87-97. [PMID: 31638459 DOI: 10.1024/0301-1526/a000823] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
14 Yu X, Doyle A. Molecular Circuit Discovery for Mechanobiology of Cardiovascular Disease. Regen Eng Transl Med . [DOI: 10.1007/s40883-022-00264-z] [Reference Citation Analysis]
15 Djerf H, Millinger J, Falkenberg M, Jivegård L, Svensson M, Nordanstig J. Absence of Long-Term Benefit of Revascularization in Patients With Intermittent Claudication: Five-Year Results From the IRONIC Randomized Controlled Trial. Circ Cardiovasc Interv 2020;13:e008450. [PMID: 31937137 DOI: 10.1161/CIRCINTERVENTIONS.119.008450] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
16 Khan A, Hughes M, Ting M, Riding G, Simpson J, Egun A, Banihani M. A 'hot clinic' for cold limbs: the benefit of urgent clinics for patients with critical limb ischaemia. Ann R Coll Surg Engl 2020;102:412-7. [PMID: 32306742 DOI: 10.1308/rcsann.2020.0068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Rafnsson SB, Fowkes G. Positive and negative well-being of older adults with symptomatic peripheral artery disease: A population-based investigation. JRSM Cardiovasc Dis 2020;9:2048004020961717. [PMID: 33520199 DOI: 10.1177/2048004020961717] [Reference Citation Analysis]
18 Longano P, Kanegusuku H, Correia MA, Puech-leao P, Wolosker N, Cucato GG, Ritti-dias RM. Are cardiovascular function and habitual physical activity levels similar in patients with classic and atypical claudication symptoms? A cross-sectional study. Vascular 2020;28:360-7. [DOI: 10.1177/1708538120911292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Cao Z, Yuan G, Zeng L, Bai L, Liu X, Wu M, Sun R, Chen Z, Jiang Y, Gao Q, Chen Y, Zhang Y, Pan Y, Wang J. Macrophage-Targeted Sonodynamic/Photothermal Synergistic Therapy for Preventing Atherosclerotic Plaque Progression Using CuS/TiO2 Heterostructured Nanosheets. ACS Nano 2022. [PMID: 35759554 DOI: 10.1021/acsnano.2c02177] [Reference Citation Analysis]
20 Xu J, Cai F, Geng C, Wang Z, Tang X. Diagnostic Performance of CMR, SPECT, and PET Imaging for the Identification of Coronary Artery Disease: A Meta-Analysis. Front Cardiovasc Med 2021;8:621389. [PMID: 34026862 DOI: 10.3389/fcvm.2021.621389] [Reference Citation Analysis]
21 Zembron-Lacny A, Dziubek W, Tylutka A, Wacka E, Morawin B, Bulinska K, Stefanska M, Wozniewski M, Szuba A. Assessment of Serum Neopterin as a Biomarker in Peripheral Artery Disease. Diagnostics (Basel) 2021;11:1911. [PMID: 34679610 DOI: 10.3390/diagnostics11101911] [Reference Citation Analysis]
22 Masmejan S, Deslarzes-Dubuis C, Petitprez S, Longchamp A, Haller C, Saucy F, Corpataux JM, Déglise S. Ten Year Experience of Using Cryopreserved Arterial Allografts for Distal Bypass in Critical Limb Ischaemia. Eur J Vasc Endovasc Surg 2019;57:823-31. [PMID: 31130420 DOI: 10.1016/j.ejvs.2018.11.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
23 Hernández D, Vázquez T, Armas-Padrón AM, Alonso-Titos J, Casas C, Gutiérrez E, Jironda C, Cabello M, López V. Peripheral Vascular Disease and Kidney Transplant Outcomes: Rethinking an Important Ongoing Complication. Transplantation 2021;105:1188-202. [PMID: 33148978 DOI: 10.1097/TP.0000000000003518] [Reference Citation Analysis]
24 Sundaram V, Bloom C, Zakeri R, Halcox J, Cohen A, Bowrin K, Briere J, Banerjee A, Simon DI, Cleland JGF, Rajagopalan S, Quint JK. Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006–2015. European Heart Journal 2020;41:1636-49. [DOI: 10.1093/eurheartj/ehz880] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
25 Hiramoto JS, Teraa M, de Borst GJ, Conte MS. Interventions for lower extremity peripheral artery disease. Nat Rev Cardiol 2018;15:332-50. [DOI: 10.1038/s41569-018-0005-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
26 Wang W, Zhao T, Geng K, Yuan G, Chen Y, Xu Y. Smoking and the Pathophysiology of Peripheral Artery Disease. Front Cardiovasc Med 2021;8:704106. [PMID: 34513948 DOI: 10.3389/fcvm.2021.704106] [Reference Citation Analysis]
27 Schawe L, Raude B, Carstens JC, Hinterseher I, Hein RD, Omran S, Berger G, Hering NA, Buerger M, Greiner A, Frese JP. Effect of Revascularization on Intramuscular Vascular Endothelial Growth Factor Levels in Peripheral Arterial Disease. Biomedicines 2022;10:471. [DOI: 10.3390/biomedicines10020471] [Reference Citation Analysis]
28 Cha JJ, Kim H, Ko YG, Choi D, Lee JH, Yoon CH, Chae IH, Yu CW, Lee SW, Lee SR, Choi SH, Koh YS, Min PK; K-VIS (Korean Vascular Intervention Society) investigators. Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort. Cardiovasc Diabetol 2020;19:97. [PMID: 32571352 DOI: 10.1186/s12933-020-01072-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Zalewski DP, Ruszel KP, Stępniewski A, Gałkowski D, Feldo M, Kocki J, Bogucka-Kocka A. Relationships between Indicators of Lower Extremity Artery Disease and miRNA Expression in Peripheral Blood Mononuclear Cells. J Clin Med 2022;11:1619. [PMID: 35329950 DOI: 10.3390/jcm11061619] [Reference Citation Analysis]
30 Tummala S, Scherbel D. Clinical Assessment of Peripheral Arterial Disease in the Office: What Do the Guidelines Say? Semin Intervent Radiol 2018;35:365-77. [PMID: 30728652 DOI: 10.1055/s-0038-1676453] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
31 Kochar A, Mulder H, Rockhold FW, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Katona BG, Lopes RD, Al-khalidi HR, Mahaffey KW, Norgren L, Hiatt WR, Patel MR, Jones WS. Cause of Death Among Patients With Peripheral Artery Disease: Insights From the EUCLID Trial. Circ: Cardiovascular Quality and Outcomes 2020;13. [DOI: 10.1161/circoutcomes.120.006550] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Saratzis A, Paraskevopoulos I, Patel S, Donati T, Biasi L, Diamantopoulos A, Zayed H, Katsanos K. Supervised Exercise Therapy and Revascularization for Intermittent Claudication: Network Meta-Analysis of Randomized Controlled Trials. JACC Cardiovasc Interv 2019;12:1125-36. [PMID: 31153838 DOI: 10.1016/j.jcin.2019.02.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
33 Roberts DJ, Nagpal SK, Kubelik D, Brandys T, Stelfox HT, Lalu MM, Forster AJ, McCartney CJ, McIsaac DI. Association between neuraxial anaesthesia or general anaesthesia for lower limb revascularisation surgery in adults and clinical outcomes: population based comparative effectiveness study. BMJ 2020;371:m4104. [PMID: 33239330 DOI: 10.1136/bmj.m4104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
34 Barenbrock H, Feld J, Lakomek A, Volkery K, Köppe J, Makowski L, Engelbertz CM, Reinecke H, Malyar N, Freisinger E. Sex-related differences in outcome after endovascular revascularization for lower extremity artery disease. Vasa 2021. [PMID: 34841885 DOI: 10.1024/0301-1526/a000978] [Reference Citation Analysis]
35 Schaller MS, Ramirez JL, Gasper WJ, Zahner GJ, Hills NK, Grenon SM. Frailty Is Associated with an Increased Risk of Major Adverse Cardiac Events in Patients with Stable Claudication. Ann Vasc Surg 2018;50:38-45. [PMID: 29477684 DOI: 10.1016/j.avsg.2017.12.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
36 Haine A, Kavanagh S, Berger JS, Hess CN, Norgren L, Fowkes FGR, Katona BG, Mahaffey KW, Blomster JI, Patel MR, Jones WS, Rockhold FW, Hiatt WR, Baumgartner I; International Steering Committee and Investigators of the EUCLID Trial. Sex-Specific Risks of Major Cardiovascular and Limb Events in Patients With Symptomatic Peripheral Artery Disease. J Am Coll Cardiol 2020;75:608-17. [PMID: 32057375 DOI: 10.1016/j.jacc.2019.11.057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
37 Hogan SE, Nehler MR, Anand S, Patel MR, Debus S, Jackson MT, Buchanan C, King RW, Hess C, Muehlhofer E, Haskell LP, Bauersachs RM, Berkowitz SD, Hsia J, Bonaca MP. Improvement in walking impairment following surgical and endovascular revascularization: Insights from VOYAGER PAD. Vasc Med 2022;:1358863X221085606. [PMID: 35467452 DOI: 10.1177/1358863X221085606] [Reference Citation Analysis]
38 Saratzis A, Jaspers NEM, Gwilym B, Thomas O, Tsui A, Lefroy R, Parks M, Htun V, Mera Z, Thatcher A, Bosanquet D, Forsythe R, Benson R, Dattani N, Dovell G, Lane T, Shalhoub J, Sidloff D, Visseren FLJ, Dorresteijn JAN, Richards T;  Vascular and Endovascular Research Network (VERN) Collaborators. Observational study of the medical management of patients with peripheral artery disease. Br J Surg. 2019;106:1168-1177. [PMID: 31259387 DOI: 10.1002/bjs.11214] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
39 Jansen-Chaparro S, López-Carmona MD, Cobos-Palacios L, Sanz-Cánovas J, Bernal-López MR, Gómez-Huelgas R. Statins and Peripheral Arterial Disease: A Narrative Review. Front Cardiovasc Med 2021;8:777016. [PMID: 34881314 DOI: 10.3389/fcvm.2021.777016] [Reference Citation Analysis]
40 Ryan TE, Schmidt CA, Tarpey MD, Amorese AJ, Yamaguchi DJ, Goldberg EJ, Iñigo MM, Karnekar R, O'Rourke A, Ervasti JM, Brophy P, Green TD, Neufer PD, Fisher-Wellman K, Spangenburg EE, McClung JM. PFKFB3-mediated glycolysis rescues myopathic outcomes in the ischemic limb. JCI Insight 2020;5:139628. [PMID: 32841216 DOI: 10.1172/jci.insight.139628] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
41 Zhao N, Yue Z, Cui J, Yao Y, Song X, Cui B, Qi X, Han Z, Han ZC, Guo Z, He ZX, Li Z. IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia. Stem Cell Res Ther 2019;10:129. [PMID: 31036073 DOI: 10.1186/s13287-019-1230-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
42 Wickström J, Virtanen J, Aro E, Jalkanen J, Venermo M, Hakovirta H. Bilateral low systolic toe pressure and toe-brachial index are associated with long-term mortality in patients with peripheral artery disease. Journal of Vascular Surgery 2019;70:1994-2004. [DOI: 10.1016/j.jvs.2019.03.073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
43 Han J, Luo L, Marcelina O, Kasim V, Wu S. Therapeutic angiogenesis-based strategy for peripheral artery disease. Theranostics 2022;12:5015-33. [PMID: 35836800 DOI: 10.7150/thno.74785] [Reference Citation Analysis]
44 Lee GS, Salazar HF, Joseph G, Lok ZSY, Caroti CM, Weiss D, Taylor WR, Lyle AN. Osteopontin isoforms differentially promote arteriogenesis in response to ischemia via macrophage accumulation and survival. Lab Invest 2019;99:331-45. [PMID: 29959420 DOI: 10.1038/s41374-018-0094-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
45 Niemann B, Rohrbach S, Miller MR, Newby DE, Fuster V, Kovacic JC. Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series. J Am Coll Cardiol. 2017;70:230-251. [PMID: 28683970 DOI: 10.1016/j.jacc.2017.05.043] [Cited by in Crossref: 125] [Cited by in F6Publishing: 117] [Article Influence: 25.0] [Reference Citation Analysis]
46 Lee JK, Hwang JJ, Chiang FT, Wu CK. The impact of left ventricular diastolic dysfunction for the prognosis in patients with lower extremity arterial disease. ESC Heart Fail 2020;7:2611-20. [PMID: 32578966 DOI: 10.1002/ehf2.12839] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Hu Y, Ling T, Yu M, Bai Y, Feng T, Zhang P, Wang Y. Apolipoprotein E Gene Polymorphism, Glycated Hemoglobin, and Peripheral Arterial Disease Risk in Chinese Type 2 Diabetic Patients. Dis Markers 2020;2020:6040525. [PMID: 32211081 DOI: 10.1155/2020/6040525] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Cooke JP, Meng S. Vascular Regeneration in Peripheral Artery Disease. Arterioscler Thromb Vasc Biol 2020;40:1627-34. [PMID: 32434408 DOI: 10.1161/ATVBAHA.120.312862] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
49 Srivastava D. Chronic post-amputation pain: peri-operative management - Review. Br J Pain. 2017;11:192-202. [PMID: 29123664 DOI: 10.1177/2049463717736492] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
50 Shirasu T, Yodsanit N, Xie X, Zhao Y, Wang Y, Xie R, Huang Y, Wang B, Urabe G, Gong S, Guo LW, Kent KC. An adventitial painting modality of local drug delivery to abate intimal hyperplasia. Biomaterials 2021;275:120968. [PMID: 34153787 DOI: 10.1016/j.biomaterials.2021.120968] [Reference Citation Analysis]
51 Beata Olas, Urbańska K, Bryś M. Selected food colourants with antiplatelet activity as promising compounds for the prophylaxis and treatment of thrombosis. Food and Chemical Toxicology 2020;141:111437. [DOI: 10.1016/j.fct.2020.111437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
52 Ding C, Wang H, Huang X, Hu L, Shi Y, Li M, Yu Y, Zhou W, Wang T, Zhu L, Bao H, Cheng X. Association between serum albumin and peripheral arterial disease in hypertensive patients. J Clin Hypertens (Greenwich) 2020;22:2250-7. [PMID: 33035388 DOI: 10.1111/jch.14071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Decker JA, Varga-Szemes A, Schoepf UJ, Emrich T, Schwarz F, Kroencke TJ, Scheurig-Muenkler C. In-patient care trends in peripheral artery disease in the German healthcare system over the past decade. Eur Radiol 2021. [PMID: 34647176 DOI: 10.1007/s00330-021-08285-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Détriché G, Guédon A, Mohamedi N, Sellami O, Cheng C, Galloula A, Goudot G, Khider L, Mortelette H, Sitruk J, Gendron N, Sapoval M, Julia P, Smadja DM, Mirault T, Messas E. Women Specific Characteristics and 1-Year Outcome Among Patients Hospitalized for Peripheral Artery Disease: A Monocentric Cohort Analysis in a Tertiary Center. Front Cardiovasc Med 2022;9:824466. [DOI: 10.3389/fcvm.2022.824466] [Reference Citation Analysis]
55 Biscetti F, Nardella E, Rando MM, Cecchini AL, Gasbarrini A, Massetti M, Flex A. Outcomes of Lower Extremity Endovascular Revascularization: Potential Predictors and Prevention Strategies. Int J Mol Sci 2021;22:2002. [PMID: 33670461 DOI: 10.3390/ijms22042002] [Reference Citation Analysis]
56 Stubbs B, Veronese N, Vancampfort D, Prina AM, Lin PY, Tseng PT, Evangelou E, Solmi M, Kohler C, Carvalho AF, Koyanagi A. Perceived stress and smoking across 41 countries: A global perspective across Europe, Africa, Asia and the Americas. Sci Rep 2017;7:7597. [PMID: 28790418 DOI: 10.1038/s41598-017-07579-w] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
57 Norgren L, North R, Baumgartner I, Berger JS, Blomster JI, Hiatt WR, Jones WS, Katona BG, Mahaffey KW, Mulder H, Patel MR, Rockhold FW, Fowkes FGR. World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial. Vasc Med 2021;:1358863X211038620. [PMID: 34516308 DOI: 10.1177/1358863X211038620] [Reference Citation Analysis]
58 Song P, Rudan D, Wang M, Chang X, Rudan I. National and subnational estimation of the prevalence of peripheral artery disease (PAD) in China: a systematic review and meta-analysis. J Glob Health 2019;9:010601. [PMID: 30873278 DOI: 10.7189/jogh.09.010601] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
59 Jia Q, Li Z, Bai M, Yan H, Zhang R, Ji Y, Feng Y, Yang Z, Wang Z, Li J. Estimating dynamic vascular perfusion based on Er-based lanthanide nanoprobes with enhanced down-conversion emission beyond 1500 nm. Theranostics 2021;11:9859-72. [PMID: 34815791 DOI: 10.7150/thno.65771] [Reference Citation Analysis]
60 Søgaard M, Nielsen PB, Skjøth F, Larsen TB, Eldrup N. Revascularisation for Symptomatic Peripheral Artery Disease: External Applicability of the VOYAGER PAD Trial. Eur J Vasc Endovasc Surg 2021:S1078-5884(21)00810-8. [PMID: 34924303 DOI: 10.1016/j.ejvs.2021.10.026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Bauersachs R, Zeymer U, Brière JB, Marre C, Bowrin K, Huelsebeck M. Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review. Cardiovasc Ther 2019;2019:8295054. [PMID: 32099582 DOI: 10.1155/2019/8295054] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 8.7] [Reference Citation Analysis]
62 Dias-Santos EG, Farah BQ, Germano-Soares AH, Correia MA, Souza AA, Hora JEJ, Ritti-Dias RM, Andrade-Lima A. Effects of Exercise Mode on Arterial Stiffness in Symptomatic Peripheral Artery Disease Patients: A Randomized Crossover Clinical Trial. Ann Vasc Surg 2021;74:382-8. [PMID: 33549795 DOI: 10.1016/j.avsg.2020.12.049] [Reference Citation Analysis]
63 Saw PE, Zhang Z, Chen Y, Li S, Huang L, Zhang C, Zhao Q, Xu X, Xiang Q. ROS-scavenging hybrid hydrogel for genetically engineered stem cell delivery and limb ischemia therapy. Chemical Engineering Journal 2021;425:131504. [DOI: 10.1016/j.cej.2021.131504] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Anand SS, Bell AD, Szalay D. The Time Has Come for Vascular Medicine in Canada. Can J Cardiol 2021;37:1677. [PMID: 33482289 DOI: 10.1016/j.cjca.2021.01.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Salaun P, Desormais I, Lapébie F, Rivière AB, Aboyans V, Lacroix P, Bataille V, Constans J, Boulon C. Comparison of Ankle Pressure, Systolic Toe Pressure, and Transcutaneous Oxygen Pressure to Predict Major Amputation After 1 Year in the COPART Cohort. Angiology 2019;70:229-36. [DOI: 10.1177/0003319718793566] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
66 Yin TC, Sung PH, Chen KH, Li YC, Luo CW, Huang CR, Sheu JJ, Chiang JY, Lee MS, Yip HK. Extracorporeal shock wave-assisted adipose-derived fresh stromal vascular fraction restores the blood flow of critical limb ischemia in rat. Vascul Pharmacol 2019;113:57-69. [PMID: 30597218 DOI: 10.1016/j.vph.2018.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
67 Korosoglou G, Giusca S, Langhoff R, Lichtenberg M, Lawall H, Schellong S, Stausberg J, Hoffmann U, Enders D, Malyar N. Safety and Effectiveness of Endovascular Therapy for the Treatment of Peripheral Artery Disease in Patients with and without Diabetes Mellitus. Angiology 2022;:33197221075857. [PMID: 35324343 DOI: 10.1177/00033197221075857] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Vrsalovic M, Vrsalovic Presecki A, Aboyans V. Cardiac troponins predict mortality and cardiovascular outcomes in patients with peripheral artery disease: A systematic review and meta-analysis of adjusted observational studies. Clin Cardiol 2022. [PMID: 35132665 DOI: 10.1002/clc.23776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Busch L, Stern M, M'Pembele R, Dannenberg L, Mourikis P, Gröne M, Özaslan G, Heinen Y, Heiss C, Sansone R, Huhn R, Kelm M, Polzin A. Impact of high on-treatment platelet reactivity after angioplasty in patients with critical limb ischemia. Vascul Pharmacol 2021;141:106925. [PMID: 34619361 DOI: 10.1016/j.vph.2021.106925] [Reference Citation Analysis]
70 Zheng L, Wang Z, Li Z, Wang M, Wang W, Chang G. MicroRNA-130a inhibits proliferation of vascular smooth muscle cells by suppressing autophagy via ATG2B. J Cell Mol Med 2021;25:3829-39. [PMID: 33611856 DOI: 10.1111/jcmm.16305] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Birkett ST, Sinclair J, Seed SA, Pymer S, Caldow E, Ingle L, Harwood AE, Egun A. Effects of exercise prescribed at different levels of claudication pain on walking performance in patients with intermittent claudication: a protocol for a randomised controlled trial. Ther Adv Cardiovasc Dis 2022;16:17539447221108817. [PMID: 35762773 DOI: 10.1177/17539447221108817] [Reference Citation Analysis]
72 Lee W, Jeong SH, Lim YW, Lee H, Kang J, Lee H, Lee I, Han HS, Kobayashi S, Tanaka M, Bae BS. Conformable microneedle pH sensors via the integration of two different siloxane polymers for mapping peripheral artery disease. Sci Adv 2021;7:eabi6290. [PMID: 34826244 DOI: 10.1126/sciadv.abi6290] [Reference Citation Analysis]
73 Sharath SE, Lee M, Kougias P, Taylor WC, Zamani N, Barshes NR. Successful Smoking Cessation Associated with Walking Behavior in Patients with Claudication. Ann Vasc Surg 2019;56:287-93. [PMID: 30500660 DOI: 10.1016/j.avsg.2018.09.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Cong G, Yan R, Sachdev U. Low serum vitamin C correlates with an increased risk of peripheral arterial disease in current smokers: Results from NHANES 2003-2004. Int J Cardiol Hypertens 2020;6:100037. [PMID: 33385159 DOI: 10.1016/j.ijchy.2020.100037] [Reference Citation Analysis]
75 Szyszkowska A, Barańska S, Sawicki R, Tarasiuk E, Dubatówka M, Kondraciuk M, Sawicka-śmiarowska E, Knapp M, Głowiński J, Kamiński K, Lisowska A. Insulin-Like Growth Factor-Binding Protein 7 (IGFBP-7)—New Diagnostic and Prognostic Marker in Symptomatic Peripheral Arterial Disease?—Pilot Study. Biomolecules 2022;12:712. [DOI: 10.3390/biom12050712] [Reference Citation Analysis]
76 Debus ES, Nehler MR, Govsyeyev N, Bauersachs RM, Anand SS, Patel MR, Fanelli F, Capell WH, Brackin T, Hinterreiter F, Krievins D, Nault P, Piffaretti G, Svetlikov A, Jaeger N, Hess CN, Sillesen HH, Conte M, Mills J, Muehlhofer E, Haskell LP, Berkowitz SD, Hiatt WR, Bonaca MP. Effect of Rivaroxaban and Aspirin in Patients with Peripheral Artery Disease Undergoing Surgical Revascularization: Insights from the VOYAGER PAD Trial. Circulation 2021. [PMID: 34380322 DOI: 10.1161/CIRCULATIONAHA.121.054835] [Reference Citation Analysis]
77 Mytinger M, Nelson RK, Zuhl M. Exercise Prescription Guidelines for Cardiovascular Disease Patients in the Absence of a Baseline Stress Test. J Cardiovasc Dev Dis 2020;7:E15. [PMID: 32349219 DOI: 10.3390/jcdd7020015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Villemur B, Thoreau V, Guinot M, Gailledrat E, Evra V, Vermorel C, Foote A, Carpentier P, Bosson J, Pérennou D. Short interval or continuous training programs to improve walking distance for intermittent claudication: Pilot study. Annals of Physical and Rehabilitation Medicine 2020;63:466-73. [DOI: 10.1016/j.rehab.2020.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
79 Arfan S, Zamzam A, Syed MH, Jain S, Jahanpour N, Abdin R, Qadura M. The Clinical Utility of D-Dimer and Prothrombin Fragment (F1+2) for Peripheral Artery Disease: A Prospective Study. Biomedicines 2022;10:878. [DOI: 10.3390/biomedicines10040878] [Reference Citation Analysis]
80 Chowdhury M, Secemsky EA. Contemporary Use of Radial to Peripheral Access for Management of Peripheral Artery Disease. Curr Treat Options Cardio Med 2021;23. [DOI: 10.1007/s11936-020-00895-x] [Reference Citation Analysis]
81 Weissler EH, Lippmann SJ, Smerek MM, Ward RA, Kansal A, Brock A, Sullivan RC, Long C, Patel MR, Greiner MA, Hardy NC, Curtis LH, Jones WS. Model-Based Algorithms for Detecting Peripheral Artery Disease Using Administrative Data From an Electronic Health Record Data System: Algorithm Development Study. JMIR Med Inform 2020;8:e18542. [PMID: 32663152 DOI: 10.2196/18542] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
82 Bauersachs R, Wu O, Hawkins N, Bowrin K, Wojciechowski P, Clay E, Huelsebeck M. Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-Analysis. Cardiovasc Ther 2021;2021:8561350. [PMID: 34497668 DOI: 10.1155/2021/8561350] [Reference Citation Analysis]
83 Ng JCK, Toong DWY, Ow V, Chaw SY, Toh H, Wong PEH, Venkatraman S, Chong TT, Tan LP, Huang YY, Ang HY. Progress in drug-delivery systems in cardiovascular applications: stents, balloons and nanoencapsulation. Nanomedicine (Lond) 2022. [PMID: 35060758 DOI: 10.2217/nnm-2021-0288] [Reference Citation Analysis]
84 Bork CS, Lasota AN, Lundbye-Christensen S, Jakobsen MU, Tjønneland A, Overvad K, Schmidt EB. Adipose tissue content of alpha-linolenic acid and development of peripheral artery disease: a Danish case-cohort study. Eur J Nutr 2020;59:3191-200. [PMID: 31832750 DOI: 10.1007/s00394-019-02159-2] [Reference Citation Analysis]
85 Krishnan P, Tarricone A, Gee A, Farhan S, Kamran H, Kini A, Sharma S. Comparison and Analysis between the NAV6 Embolic Protection Filter and SpiderFX EPD Filter in Superficial Femoral Artery Lesions. J Interv Cardiol 2021;2021:9047596. [PMID: 34149323 DOI: 10.1155/2021/9047596] [Reference Citation Analysis]
86 Barrios V, Beato P, Brotons C, Campuzano R, Merino-torres J, Mostaza J, Plana N, Rubio J, Comellas M. Manejo integral de los factores de riesgo en enfermedad arterial periférica. Consenso de expertos. Revista Clínica Española 2022;222:82-90. [DOI: 10.1016/j.rce.2020.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
87 Wang CY, Hsiao CY, Tsai KL, Cheng YH. Injectable thermosensitive chitosan-based hydrogel containing ferulic acid for treating peripheral arterial disease. J Tissue Eng Regen Med 2020;14:1438-48. [PMID: 32767844 DOI: 10.1002/term.3109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Danieluk A, Chlabicz S. Automated Measurements of Ankle-Brachial Index: A Narrative Review. J Clin Med 2021;10:5161. [PMID: 34768679 DOI: 10.3390/jcm10215161] [Reference Citation Analysis]
89 Chen L, Liu H, Yuan M, Lu W, Wang J, Wang T. The roles of interleukins in perfusion recovery after peripheral arterial disease. Biosci Rep 2018;38:BSR20171455. [PMID: 29358309 DOI: 10.1042/BSR20171455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
90 Ponraj DGS, Gopikrishnan SK, Newtonraj A, Arokiaraj MC, Purty AJ, Nanda SK, Manikandan M, Vincent A. Cardiovascular risk using WHO-ISH chart among Diabetes and Hypertensive patients in a remote rural area of South India. J Family Med Prim Care 2020;9:4145-50. [PMID: 33110823 DOI: 10.4103/jfmpc.jfmpc_538_20] [Reference Citation Analysis]
91 de Macedo Ribeiro FRC, Ribeiro CHMA, Tavoni TM, Dos Santos Sarges E, Freitas FR, Stolf NAG, Kalil Filho R, Maranhão RC. Disturbances of the transfer of cholesterol to high-density lipoprotein (HDL) in patients with peripheral artery disease with or without type 2 diabetes mellitus. Vasc Med 2021;26:602-7. [PMID: 34137646 DOI: 10.1177/1358863X211021142] [Reference Citation Analysis]
92 Babber A, Ravikumar R, Onida S, Lane TRA, Davies AH. Effect of footplate neuromuscular electrical stimulation on functional and quality-of-life parameters in patients with peripheral artery disease: pilot, and subsequent randomized clinical trial. Br J Surg 2020;107:355-63. [PMID: 31912491 DOI: 10.1002/bjs.11398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
93 Kip P, Sluiter TJ, Moore JK, Hart A, Ruske J, O'Leary J, Jung J, Tao M, MacArthur MR, Heindel P, de Jong A, de Vries MR, Burak MF, Mitchell SJ, Mitchell JR, Ozaki CK. Short-Term Pre-Operative Protein Caloric Restriction in Elective Vascular Surgery Patients: A Randomized Clinical Trial. Nutrients 2021;13:4024. [PMID: 34836280 DOI: 10.3390/nu13114024] [Reference Citation Analysis]
94 Li Q, Qin L, Li J. Effects of bradykinin on voltage-gated KV 4 channels in muscle dorsal root ganglion neurons of rats with experimental peripheral artery disease. J Physiol 2021;599:3567-80. [PMID: 34036586 DOI: 10.1113/JP281704] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Samman Tahhan A, Hayek SS, Sandesara P, Hajjari J, Hammadah M, O'Neal WT, Kelli HM, Alkhoder A, Ghasemzadeh N, Ko YA, Aida H, Gafeer MM, Abdelhadi N, Mohammed KH, Patel K, Arya S, Reiser J, Vaccarino V, Sperling L, Quyyumi A. Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes. Atherosclerosis 2017;264:108-14. [PMID: 28728756 DOI: 10.1016/j.atherosclerosis.2017.06.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
96 Ferreira CA, Hernandez R, Yang Y, Valdovinos HF, Engle JW, Cai W. ImmunoPET of CD146 in a Murine Hindlimb Ischemia Model. Mol Pharm 2018;15:3434-41. [PMID: 29889530 DOI: 10.1021/acs.molpharmaceut.8b00424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
97 Johnson LL, Johnson J, Ali Z, Tekabe Y, Ober R, Geist G, McLuckie A, Safarov A, Holland A, Zhang G, Backer M, Backer J. VEGF receptor targeted imaging of angiogenic response to limb ischemia in diabetic vs. non-diabetic Yucatan minipigs. EJNMMI Res 2020;10:48. [PMID: 32399850 DOI: 10.1186/s13550-020-00626-0] [Reference Citation Analysis]
98 Park JH, Soh S, Kwak YL, Kim B, Choi S, Shim JK. Anesthetic Efficacy of Dexmedetomidine versus Midazolam When Combined with Remifentanil for Percutaneous Transluminal Angioplasty in Patients with Peripheral Artery Disease. J Clin Med 2019;8:E472. [PMID: 30959941 DOI: 10.3390/jcm8040472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
99 Lamberti N, Caruso L, Piva G, Traina L, Ficarra V, Zamboni P, Gasbarro V, Manfredini F. Beyond the Patient's Report: Self-Reported, Subjective, Objective and Estimated Walking Disability in Patients with Peripheral Artery Disease. Diagnostics (Basel) 2021;11:1991. [PMID: 34829337 DOI: 10.3390/diagnostics11111991] [Reference Citation Analysis]
100 Liu H, Zha X, Ding C, Hu L, Li M, Yu Y, Zhou W, Wang T, Zhu L, Bao H, Cheng X. AST/ALT Ratio and Peripheral Artery Disease in a Chinese Hypertensive Population: A Cross-Sectional Study. Angiology 2021;:33197211004410. [PMID: 33779311 DOI: 10.1177/00033197211004410] [Reference Citation Analysis]
101 Golledge J, Rowbotham S, Velu R, Quigley F, Jenkins J, Bourke M, Bourke B, Thanigaimani S, Chan DC, Watts GF. Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease. J Am Heart Assoc 2020;9:e015355. [PMID: 32172653 DOI: 10.1161/JAHA.119.015355] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
102 Osinski V, Srikakulapu P, Haider YM, Marshall MA, Ganta VC, Annex BH, McNamara CA. Loss of Id3 (Inhibitor of Differentiation 3) Increases the Number of IgM-Producing B-1b Cells in Ischemic Skeletal Muscle Impairing Blood Flow Recovery During Hindlimb Ischemia. Arterioscler Thromb Vasc Biol 2022;42:6-18. [PMID: 34809449 DOI: 10.1161/ATVBAHA.120.315501] [Reference Citation Analysis]
103 Amidou SA, Houehanou YC, Houinato SD, Aboyans V, Sonou A, Saka D, Houinato M, Desormais I, Magne J, Houenassi MD, Preux PM, Lacroix P; TAHES Group. Epidemiology of lower extremity artery disease in a rural setting in Benin, West Africa: The TAHES study. Int J Cardiol 2018;267:198-201. [PMID: 29859709 DOI: 10.1016/j.ijcard.2018.05.099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
104 Nowrouzi A, Benitez-Del-Castillo J, Kafi-Abasabadi S, Rodriguez-Calzadilla M, Diaz-Ramos A, Rodriguez-Suarez A, Mota-Chozas I. Peripheral vascular disease - a new vascular disease associated with normal tension glaucoma: a case report. J Med Case Rep 2020;14:224. [PMID: 33208187 DOI: 10.1186/s13256-020-02533-3] [Reference Citation Analysis]
105 Chen GC, Arthur R, Mossavar-Rahmani Y, Xue X, Haring B, Shadyab AH, Allison MA, Liu S, Tinker LF, Saquib N, Coday M, Shikany JM, Neuhouser ML, Snetselaar LG, Van Horn L, Rohan TE, Wassertheil-Smoller S, Kaplan RC, Qi Q. Adherence to Recommended Eating Patterns Is Associated With Lower Risk of Peripheral Arterial Disease: Results From the Women's Health Initiative. Hypertension 2021;78:447-55. [PMID: 34176290 DOI: 10.1161/HYPERTENSIONAHA.121.17432] [Reference Citation Analysis]
106 Martin-ventura JL, Roncal C, Orbe J, Blanco-colio LM. Role of Extracellular Vesicles as Potential Diagnostic and/or Therapeutic Biomarkers in Chronic Cardiovascular Diseases. Front Cell Dev Biol 2022;10:813885. [DOI: 10.3389/fcell.2022.813885] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
107 Farah BQ, Santos MF, Cucato GG, Kanegusuku H, Sampaio LMM, Monteiro FA, Wolosker N, Puech-Leão P, Correia MA, Ritti-Dias RM. Effect of frailty on physical activity levels and walking capacity in patients with peripheral artery disease: A cross-sectional study. J Vasc Nurs 2021;39:84-8. [PMID: 34507705 DOI: 10.1016/j.jvn.2021.07.001] [Reference Citation Analysis]
108 Pu H, Huang Q, Zhang X, Wu Z, Qiu P, Jiang Y, Wang R, Zhao Z, Xu Z, Qin J, Lu X, Li W. A Meta-Analysis of Randomized Controlled Trials on Therapeutic Efficacy and Safety of Autologous Cell Therapy for Atherosclerosis Obliterans. J Vasc Surg 2021:S0741-5214(21)02437-X. [PMID: 34788653 DOI: 10.1016/j.jvs.2021.10.051] [Reference Citation Analysis]
109 Qato K, Bahroloomi D, Conway A, Lu E, Pamoukian V, Giangola G, Carroccio A. Contemporary outcomes of initial treatment strategy of endovascular intervention or bypass in patients with critical limb ischemia. Vascular 2022;:17085381221107749. [PMID: 35698916 DOI: 10.1177/17085381221107749] [Reference Citation Analysis]
110 Elorza Ridaura I, Sorrentino S, Moroni L. Parallels between the Developing Vascular and Neural Systems: Signaling Pathways and Future Perspectives for Regenerative Medicine. Adv Sci (Weinh) 2021;8:e2101837. [PMID: 34693660 DOI: 10.1002/advs.202101837] [Reference Citation Analysis]
111 Agius PA, Cutts JC, Song P, Rudan I, Rudan D, Aboyans V, McDermott MM, Criqui MH, Fowkes FGR, Fowkes FJI. The Global Epidemiological Transition in Cardiovascular Diseases: Unrecognised Impact of Endemic Infections on Peripheral Artery Disease. J Epidemiol Glob Health 2022. [PMID: 35841531 DOI: 10.1007/s44197-022-00049-1] [Reference Citation Analysis]
112 Saenz-Pipaon G, Martinez-Aguilar E, Orbe J, González Miqueo A, Fernandez-Alonso L, Paramo JA, Roncal C. The Role of Circulating Biomarkers in Peripheral Arterial Disease. Int J Mol Sci 2021;22:3601. [PMID: 33808453 DOI: 10.3390/ijms22073601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
113 Wang Z, Wang X, Hao G, Chen Z, Zhang L, Shao L, Tian Y, Dong Y, Zheng C, Kang Y, Gao R. A national study of the prevalence and risk factors associated with peripheral arterial disease from China: The China Hypertension Survey, 2012–2015. International Journal of Cardiology 2019;275:165-70. [DOI: 10.1016/j.ijcard.2018.10.047] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
114 Chen L, He W, Peng B, Yuan M, Wang N, Wang J, Lu W, Wang T. Sodium Tanshinone IIA sulfonate improves post-ischemic angiogenesis in hyperglycemia. Biochemical and Biophysical Research Communications 2019;520:580-5. [DOI: 10.1016/j.bbrc.2019.09.106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
115 Buso G, Aboyans V, Mazzolai L. Lower extremity artery disease in patients with type 2 diabetes. Eur J Prev Cardiol 2019;26:114-24. [PMID: 31766923 DOI: 10.1177/2047487319880044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
116 Gähwiler R, Thalhammer C. A COMPASS for VOYAGERs with revascularized peripheral artery disease. Vasa 2020;49:427-8. [PMID: 32856573 DOI: 10.1024/0301-1526/a000864] [Reference Citation Analysis]
117 Agnelli G, Belch JJF, Baumgartner I, Giovas P, Hoffmann U. Morbidity and mortality associated with atherosclerotic peripheral artery disease: A systematic review. Atherosclerosis 2020;293:94-100. [PMID: 31606132 DOI: 10.1016/j.atherosclerosis.2019.09.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 8.3] [Reference Citation Analysis]
118 Ghibes P, Hefferman G, Nikolaou K, Syha R, Artzner C, Grosse U, Hoffmann R, Grözinger G. Quantitative Evaluation of Peripheral Arterial Blood Flow Using Peri-Interventional Fluoroscopic Parameters: An In Vivo Study Evaluating Feasibility and Clinical Utility. Biomed Res Int 2020;2020:9526790. [PMID: 32190691 DOI: 10.1155/2020/9526790] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
119 Zaccagnini G, Maimone B, Fuschi P, Longo M, Da Silva D, Carrara M, Voellenkle C, Perani L, Esposito A, Gaetano C, Martelli F. Hypoxia-Induced miR-210 Is Necessary for Vascular Regeneration upon Acute Limb Ischemia. Int J Mol Sci 2019;21:E129. [PMID: 31878120 DOI: 10.3390/ijms21010129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
120 Shahid A, Stenson TH, Mcmurtry MS. Normoxic low-altitude simulation (at 714 mmHg) improves limb blood perfusion in mice with hindlimb ischemia. Physiol Rep 2021;9:e14228. [PMID: 33502830 DOI: 10.14814/phy2.14228] [Reference Citation Analysis]
121 Bonaca MP, Hess CN. ASCVD Risk and Statin Use in PAD: Implementing a New Approach to an Old Problem. J Am Coll Cardiol 2020;76:265-7. [PMID: 32674790 DOI: 10.1016/j.jacc.2020.06.009] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Morrison JT, Hsia J, Bonaca MP; Department of Medicine, Division of Cardiovascular Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA, Colorado Prevention Center (CPC) Clinical Research, Aurora, CO, USA, Department of Medicine, Division of Cardiovascular Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA, Colorado Prevention Center (CPC) Clinical Research, Aurora, CO, USA, Department of Medicine, Division of Cardiovascular Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA, Colorado Prevention Center (CPC) Clinical Research, Aurora, CO, USA. Medical Therapy for Secondary Prevention of Atherothrombotic Events in Peripheral Artery Disease. Heart International 2021;15:14. [DOI: 10.17925/hi.2021.15.1.14] [Reference Citation Analysis]
123 Echouffo-Tcheugui JB, Kengne AP. Prediction of individualized lifetime benefit from cardiovascular risk-reducing interventions in apparently healthy people. Eur Heart J 2020;41:1200-2. [PMID: 31369081 DOI: 10.1093/eurheartj/ehz515] [Reference Citation Analysis]
124 Golledge J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat Rev Cardiol 2022. [PMID: 34997200 DOI: 10.1038/s41569-021-00663-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
125 Collins GC, Brumfiel TA, Bercu ZL, Desai JP, Lindsey BD. Dual-Resonance (16/32 MHz) Piezoelectric Transducer With a Single Electrical Connection for Forward-Viewing Robotic Guidewire. IEEE Trans Ultrason Ferroelectr Freq Control 2022;69:1428-41. [PMID: 35143395 DOI: 10.1109/TUFFC.2022.3150746] [Reference Citation Analysis]
126 Lanthier L, Huard G, Plourde ME, Cauchon M. [In patient with symptomatic peripheral arterial disease who had undergone lower-extremity revascularization, does rivaroxaban 2.5 mg twice daily plus aspirin reduce the composite risk of acute limb ischemia, major amputation for vascular causes, myocardial infarction, ischemic stroke or cardiovascular death compared to aspirin alone while being safe?]. Rev Med Interne 2020;41:571-2. [PMID: 32798088 DOI: 10.1016/j.revmed.2020.07.004] [Reference Citation Analysis]
127 Chen P, Lee M, Tang S, Huang P, Yeh H, Jia-yin Hou C, Hsieh I, Lee J, Jeng J, Li Y. 2022 focused update of the 2017 Taiwan lipid guidelines for high risk patients: Coronary artery disease, peripheral artery disease and ischemic stroke. Journal of the Formosan Medical Association 2022. [DOI: 10.1016/j.jfma.2022.03.001] [Reference Citation Analysis]
128 Ašćerić RR, Dimković NB, Trajković GŽ, Ristić BS, Janković AN, Durić PS, Ilijevski NS. Prevalence, clinical characteristics, and predictors of peripheral arterial disease in hemodialysis patients: a cross-sectional study. BMC Nephrol 2019;20:281. [PMID: 31349820 DOI: 10.1186/s12882-019-1468-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
129 Troidl K, Schubert C, Vlacil AK, Chennupati R, Koch S, Schütt J, Oberoi R, Schaper W, Schmitz-Rixen T, Schieffer B, Grote K. The Lipopeptide MALP-2 Promotes Collateral Growth. Cells 2020;9:E997. [PMID: 32316253 DOI: 10.3390/cells9040997] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
130 Huillca MA, Moreno-Loaiza M, Tipacti-Rodríguez F, Briceño-Alvarado M, Llalle WSC. Endovascular revascularization of chronic total arterial occlusion of the lower limb using the SAFARI technique. J Vasc Bras 2021;20:e20200126. [PMID: 34093686 DOI: 10.1590/1677-5449.200126] [Reference Citation Analysis]
131 Aboyans V, Sevestre M, Désormais I, Lacroix P, Fowkes G, Criqui MH. Épidémiologie de l’artériopathie des membres inférieurs. La Presse Médicale 2018;47:38-46. [DOI: 10.1016/j.lpm.2018.01.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
132 Kotalczyk A, Vallabhaneni SR, Lip GYH. Review new concepts in pharmacotherapy for peripheral arterial disease. Curr Opin Cardiol 2021;36:720-6. [PMID: 34620790 DOI: 10.1097/HCO.0000000000000883] [Reference Citation Analysis]
133 Chen H, Yu N, Cheng Y. Shear-thinning hydrogels containing reactive oxygen species-responsive nanoparticles for salvianolic acid B delivery to rescue oxidative damaged HUVECs. European Polymer Journal 2022;164:110982. [DOI: 10.1016/j.eurpolymj.2021.110982] [Reference Citation Analysis]
134 Kim K, Ro B, Damen FW, Gramling DP, Lehr TD, Song Q, Goergen CJ, Roseguini BT. Heat therapy improves body composition and muscle function but does not affect capillary or collateral growth in a model of obesity and hindlimb ischemia. J Appl Physiol (1985) 2021;130:355-68. [PMID: 33180645 DOI: 10.1152/japplphysiol.00535.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
135 Emery C, Torreton E, Briere JB, Evers T, Fagnani F. Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis. J Med Econ 2020;23:513-20. [PMID: 31928390 DOI: 10.1080/13696998.2020.1715415] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
136 Villemoes MK, Lindholt JS, Houlind KC, Gottschalksen B, Petersen CN, Rasmussen M, Wedel C, Bramsen MB, Søgaard R. Cost-Effectiveness Evaluation of Heparin Coated Versus Standard Graft for Bypass Surgery in Peripheral Artery Disease Alongside a Randomised Controlled Trial. Eur J Vasc Endovasc Surg 2018;56:87-93. [PMID: 29622512 DOI: 10.1016/j.ejvs.2018.03.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
137 Eid MA, Mehta KS, Goodney PP. Epidemiology of peripheral artery disease. Semin Vasc Surg 2021;34:38-46. [PMID: 33757634 DOI: 10.1053/j.semvascsurg.2021.02.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
138 Emanuelsson F, Benn M. LDL-Cholesterol versus Glucose in Microvascular and Macrovascular Disease. Clin Chem 2021;67:167-82. [PMID: 33221847 DOI: 10.1093/clinchem/hvaa242] [Reference Citation Analysis]
139 Phi Thi Nguyen N, Luong Cong T, Tran TTH, Nhu Do B, Tien Nguyen S, Thanh Vu B, Ho Thi Nguyen L, Van Ngo M, Trung Dinh H, Duong Huy H, Xuan Vu N, Nguyen Trung K, Ngoc Vu D, The Pham N, Dinh Le T. Lower Plasma Albumin, Higher White Blood Cell Count and High-Sensitivity C-Reactive Protein are Associated with Femoral Artery Intima-Media Thickness Among Newly Diagnosed Patients with Type 2 Diabetes Mellitus. IJGM 2022;Volume 15:2715-25. [DOI: 10.2147/ijgm.s351342] [Reference Citation Analysis]
140 Lee IT. Mean and variability of annual haemoglobin A1c are associated with high-risk peripheral artery disease. Diab Vasc Dis Res 2020;17:1479164120909030. [PMID: 32148085 DOI: 10.1177/1479164120909030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Bogucka-Kocka A, Zalewski DP, Ruszel KP, Stępniewski A, Gałkowski D, Bogucki J, Komsta Ł, Kołodziej P, Zubilewicz T, Feldo M, Kocki J. Dysregulation of MicroRNA Regulatory Network in Lower Extremities Arterial Disease. Front Genet 2019;10:1200. [PMID: 31827490 DOI: 10.3389/fgene.2019.01200] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
142 Rebuffet C, Gillois P, Joly M, Satger B, Seinturier C, Pernod G. Evaluation of socio-economic insecurity in peripheral artery disease patients. J Med Vasc 2021;46:108-13. [PMID: 33990284 DOI: 10.1016/j.jdmv.2021.03.001] [Reference Citation Analysis]
143 Rojas-Torres M, Jiménez-Palomares M, Martín-Ramírez J, Beltrán-Camacho L, Sánchez-Gomar I, Eslava-Alcon S, Rosal-Vela A, Gavaldá S, Durán-Ruiz MC. REX-001, a BM-MNC Enriched Solution, Induces Revascularization of Ischemic Tissues in a Murine Model of Chronic Limb-Threatening Ischemia. Front Cell Dev Biol 2020;8:602837. [PMID: 33363160 DOI: 10.3389/fcell.2020.602837] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
144 Makowski L, Feld J, Köppe J, Illner J, Kühnemund L, Wiederhold A, Dröge P, Günster C, Gerß J, Reinecke H, Freisinger E. Sex related differences in therapy and outcome of patients with intermittent claudication in a real-world cohort. Atherosclerosis 2021;325:75-82. [PMID: 33901740 DOI: 10.1016/j.atherosclerosis.2021.03.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Golledge J, Drovandi A, Rowbotham S, Velu R, Quigley F, Jenkins J. Control of modifiable risk factors and major adverse cardiovascular events in people with peripheral artery disease and diabetes. World J Diabetes 2021; 12(6): 883-892 [PMID: 34168735 DOI: 10.4239/wjd.v12.i6.883] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
146 Zielinski LP, Chowdhury MM, Coughlin PA. Patient and Institutional Costs of Failure of Angioplasty of the Superficial Femoral Artery. Ann Vasc Surg 2021;72:218-26. [PMID: 32889162 DOI: 10.1016/j.avsg.2020.08.106] [Reference Citation Analysis]
147 Farber A, Rosenfield K, Siami FS, Strong M, Menard M. The BEST-CLI trial is nearing the finish line and promises to be worth the wait. J Vasc Surg 2019;69:470-481.e2. [PMID: 30683195 DOI: 10.1016/j.jvs.2018.05.255] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
148 Malyar N, Stausberg J, Langhoff R, Tatò F, Kalka C, Ito WD, Böhme J, Arjumand J, Stegemann J, Lawall H, Schellong S, Lichtenberg M, Hoffmann U. Demographic and procedural characteristics in the RECording COurses of vasculaR Diseases (RECCORD) registry – the first 1000 patients. Vasa 2020;49:382-8. [DOI: 10.1024/0301-1526/a000882] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
149 Sopariwala DH, Likhite N, Pei G, Haroon F, Lin L, Yadav V, Zhao Z, Narkar VA. Estrogen-related receptor α is involved in angiogenesis and skeletal muscle revascularization in hindlimb ischemia. FASEB J 2021;35:e21480. [PMID: 33788962 DOI: 10.1096/fj.202001794RR] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Pellenc Q, Girault A, Roussel A, Aguir S, Cerceau P, Longrois D, Mal H, Mordant P, Castier Y. Preclosing of the femoral artery allows total percutaneous venoarterial extracorporeal membrane oxygenation and prevents groin wound infection after lung transplantation. Eur J Cardiothorac Surg 2020;58:371-8. [PMID: 32083665 DOI: 10.1093/ejcts/ezaa039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
151 Le Hello C, Fouillet L, Boulon C, Rivière S, El Jaouhari A, Seffert B, Morel A, Boissier C. [Lower-limb peripheral arterial disease]. Rev Med Interne 2020;41:667-72. [PMID: 32359979 DOI: 10.1016/j.revmed.2020.03.009] [Reference Citation Analysis]
152 Lu Y, Ballew SH, Kwak L, Selvin E, Kalbaugh CA, Schrack JA, Matsushita K, Szklo M. Physical Activity and Subsequent Risk of Hospitalization With Peripheral Artery Disease and Critical Limb Ischemia in the ARIC Study. J Am Heart Assoc 2019;8:e013534. [PMID: 31642360 DOI: 10.1161/JAHA.119.013534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
153 Colombo M, Luraghi G, Cestariolo L, Ravasi M, Airoldi A, Chiastra C, Pennati G. Impact of lower limb movement on the hemodynamics of femoropopliteal arteries: A computational study. Medical Engineering & Physics 2020;81:105-17. [DOI: 10.1016/j.medengphy.2020.05.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
154 Kim C, Yang YS, Ryu GW, Choi M. Risk factors associated with amputation-free survival for patients with peripheral arterial disease: a systematic review. Eur J Cardiovasc Nurs 2021;20:295-304. [PMID: 33786599 DOI: 10.1093/eurjcn/zvaa022] [Reference Citation Analysis]
155 Ismaeel A, Lavado R, Smith RS, Eidson JL, Sawicki I, Kirk JS, Bohannon WT, Koutakis P. Effects of Limb Revascularization Procedures on Oxidative Stress. Journal of Surgical Research 2018;232:503-9. [DOI: 10.1016/j.jss.2018.07.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
156 Shimotsu R, Hotta K, Ikegami R, Asamura T, Tabuchi A, Masamoto K, Yagishita K, Poole DC, Kano Y. Vascular permeability of skeletal muscle microvessels in rat arterial ligation model: in vivo analysis using two-photon laser scanning microscopy. Am J Physiol Regul Integr Comp Physiol 2021;320:R972-83. [PMID: 33949210 DOI: 10.1152/ajpregu.00135.2020] [Reference Citation Analysis]
157 Reiner Ž, De Sutter J, Ryden L, Mirrakhimov E, Pogosova N, Dolzhenko M, Fras Z, Kotseva K, Wood D, De Bacquer D. Peripheral arterial disease and intermittent claudication in coronary heart disease patients. Int J Cardiol 2021;322:227-32. [PMID: 32918939 DOI: 10.1016/j.ijcard.2020.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
158 Buso G, Darioli R, Calanca L, Depairon M, Schwitter J, Mazzolai L, Alatri A. In postmenopausal women, lower limb peripheral arterial disease, assessed by ankle-brachial index, may be a strong predictor of cardiovascular risk. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.02.002] [Reference Citation Analysis]
159 Cardoso CRL, Melo JV, Santos TRM, Leite NC, Salles GF. Traditional and non-traditional risk factors for peripheral artery disease development/progression in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study. Cardiovasc Diabetol 2021;20:54. [PMID: 33639945 DOI: 10.1186/s12933-021-01249-y] [Reference Citation Analysis]
160 Ding C, Chen Y, Shi Y, Li M, Hu L, Zhou W, Wang T, Zhu L, Huang X, Bao H, Cheng X. Association between nontraditional lipid profiles and peripheral arterial disease in Chinese adults with hypertension. Lipids Health Dis 2020;19:231. [PMID: 33143696 DOI: 10.1186/s12944-020-01407-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Peppas S, Sagris M, Bikakis I, Giannopoulos S, Tzoumas A, Kokkinidis DG, Ahmed Z, Korosoglou G, Malgor EA, Malgor RD. A Systematic Review and Meta-analysis on the Efficacy and Safety of Direct Oral Anticoagulants in Patients with Peripheral Artery Disease. Ann Vasc Surg 2021:S0890-5096(21)00674-9. [PMID: 34644644 DOI: 10.1016/j.avsg.2021.07.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
162 Woo K, Siracuse JJ, Klingbeil K, Kraiss LW, Osborne N, Singh N, Tan TW, Arya S, Banerjee S, Bonaca MP, Brothers T, Conte MS, Dawson DL, Erben Y, Lerner BM, Lin JC, Mills JL Sr, Mittleider D, Nair DG, O'Banion LA, Patterson RB, Scheidt MJ, Simons JP; Society for Vascular Surgery Appropriateness Committee. Society for Vascular Surgery Appropriate Use Criteria for Management of Intermittent Claudication. J Vasc Surg 2022:S0741-5214(22)01478-1. [PMID: 35470016 DOI: 10.1016/j.jvs.2022.04.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Ivan E, Martinsen B, Igyarto Z, Sublett T, Nachimuthu S. Peripheral Artery Disease in Vulnerable Patient Populations: Outcomes of Orbital Atherectomy in Native Americans Compared to Non-Native Americans. A Single-Center Experience in Rural Oklahoma. Cardiovasc Revasc Med 2021;22:71-7. [PMID: 32651160 DOI: 10.1016/j.carrev.2020.06.008] [Reference Citation Analysis]
164 Chen L, Zhang D, Shi L, Kalbaugh CA. Disparities in Peripheral Artery Disease Hospitalizations Identified Among Understudied Race-Ethnicity Groups. Front Cardiovasc Med 2021;8:692236. [PMID: 34109228 DOI: 10.3389/fcvm.2021.692236] [Reference Citation Analysis]
165 Thomas SG, Marzolini S, Lin E, Nguyen CH, Oh P. Peripheral Arterial Disease: Supervised Exercise Therapy Through Cardiac Rehabilitation. Clin Geriatr Med 2019;35:527-37. [PMID: 31543183 DOI: 10.1016/j.cger.2019.07.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 St Hilaire C. Medial Arterial Calcification: A Significant and Independent Contributor of Peripheral Artery Disease. Arterioscler Thromb Vasc Biol 2022;42:253-60. [PMID: 35081727 DOI: 10.1161/ATVBAHA.121.316252] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
167 Tsai S, Li Y, Lee C, Cha S, Wang Y, Su T, Yu S, Yeh C. Mono or Dual Antiplatelet Therapy for Treating Patients with Peripheral Artery Disease after Lower Extremity Revascularization: A Systematic Review and Meta-Analysis. Pharmaceuticals 2022;15:596. [DOI: 10.3390/ph15050596] [Reference Citation Analysis]
168 Kosmac K, Gonzalez-Freire M, McDermott MM, White SH, Walton RG, Sufit RL, Tian L, Li L, Kibbe MR, Criqui MH, Guralnik JM, S Polonsky T, Leeuwenburgh C, Ferrucci L, Peterson CA. Correlations of Calf Muscle Macrophage Content With Muscle Properties and Walking Performance in Peripheral Artery Disease. J Am Heart Assoc 2020;9:e015929. [PMID: 32390569 DOI: 10.1161/JAHA.118.015929] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
169 Siegal DM, Anand SS. Considerations for use of direct oral anticoagulants in arterial disease. Res Pract Thromb Haemost 2021;5. [PMID: 34095731 DOI: 10.1002/rth2.12502] [Reference Citation Analysis]
170 Kronlage M, Erbel C, Lichtenberg M, Heinrich U, Katus HA, Frey N, Giusca S, Korosoglou G. Safety and effectiveness of Phoenix atherectomy for endovascular treatment in calcified common femoral artery lesions. Vasa 2021;50:378-86. [PMID: 34155913 DOI: 10.1024/0301-1526/a000960] [Reference Citation Analysis]
171 Dikilitas O, Satterfield BA, Kullo IJ. Risk Factors for Polyvascular Involvement in Patients With Peripheral Artery Disease: A Mendelian Randomization Study. J Am Heart Assoc 2020;9:e017740. [PMID: 33287626 DOI: 10.1161/JAHA.120.017740] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
172 Torres A, Bidarra S, Pinto M, Aguiar P, Silva E, Barrias C. Guiding morphogenesis in cell-instructive microgels for therapeutic angiogenesis. Biomaterials 2018;154:34-47. [DOI: 10.1016/j.biomaterials.2017.10.051] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
173 Krankenberg H. [Recommended interventions for the treatment of peripheral artery disease : Keep the patients moving]. Internist (Berl) 2019;60:1235-9. [PMID: 31667527 DOI: 10.1007/s00108-019-00695-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
174 Makino Y, Miyahara T, Nitta J, Miyahara K, Seo A, Kimura M, Suhara M, Akai A, Akagi D, Yamamoto K, Hoshina K. Proresolving Lipid Mediators Resolvin D1 and Protectin D1 Isomer Attenuate Neointimal Hyperplasia in the Rat Carotid Artery Balloon Injury Model. Journal of Surgical Research 2019;233:104-10. [DOI: 10.1016/j.jss.2018.07.049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
175 Norgren L, North R, Baumgartner I, Berger JS, Blomster JI, Hiatt WR, Jones WS, Katona BG, Mahaffey KW, Mulder H, Patel MR, Rockhold FW, Fowkes FGR. World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial. Vasc Med 2022;27:21-9. [PMID: 34516308 DOI: 10.1177/1358863X211038620] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
176 Zhu L, Hu B, Guo Y, Yang H, Zheng J, Yao X, Hu H, Liu H. Effect of Chitosan oligosaccharides on ischemic symptom and gut microbiota disbalance in mice with hindlimb ischemia. Carbohydr Polym 2020;240:116271. [PMID: 32475560 DOI: 10.1016/j.carbpol.2020.116271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
177 Beltrán-Camacho L, Rojas-Torres M, Durán-Ruiz MC. Current Status of Angiogenic Cell Therapy and Related Strategies Applied in Critical Limb Ischemia. Int J Mol Sci 2021;22:2335. [PMID: 33652743 DOI: 10.3390/ijms22052335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
178 Lee WH, Hsu PC, Huang JC, Chen YC, Chen SC, Wu PY, Lee MK, Lee CS, Yen HW, Su HM. Association of Pulse Volume Recording at Ankle with Total and Cardiovascular Mortality in Hemodialysis Patients. J Clin Med 2019;8:E2045. [PMID: 31766504 DOI: 10.3390/jcm8122045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
179 Colombo M, Corti A, Gallo D, Colombo A, Antognoli G, Bernini M, Mckenna C, Berceli S, Vaughan T, Migliavacca F, Chiastra C. Superficial femoral artery stenting: Impact of stent design and overlapping on the local hemodynamics. Computers in Biology and Medicine 2022. [DOI: 10.1016/j.compbiomed.2022.105248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
180 Hess CN, Baumgartner I, Anand SS, Nehler MR, Patel MR, Debus ES, Szarek M, Capell W, Muehlhofer E, Berkowitz SD, Haskell LP, Bauersachs RM, Bonaca MP, Hsia J. Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD. J Am Heart Assoc 2022;11:e024655. [PMID: 35699170 DOI: 10.1161/JAHA.121.024655] [Reference Citation Analysis]
181 Goldstein RL, McCormack MC, Mallidi S, Runyan G, Randolph MA, Austen WG Jr, Redmond RW. Photochemical Tissue Passivation of Arteriovenous Grafts Prevents Long-Term Development of Intimal Hyperplasia in a Swine Model. J Surg Res 2020;253:280-7. [PMID: 32402853 DOI: 10.1016/j.jss.2020.03.006] [Reference Citation Analysis]
182 Sung P, Yin T, Chai H, Chiang JY, Chen C, Huang C, Yip H. Extracorporeal Shock Wave Therapy Salvages Critical Limb Ischemia in B6 Mice through Upregulating Cell Proliferation Signaling and Angiogenesis. Biomedicines 2022;10:117. [DOI: 10.3390/biomedicines10010117] [Reference Citation Analysis]
183 Ilonzo N, Goldberger C, Hwang S, Rao A, Faries P, Marin M, Tadros R. The Effect of Patient and Hospital Characteristics on Total Costs of Peripheral Bypass in New York State. Vasc Endovascular Surg 2021;55:434-40. [PMID: 33590811 DOI: 10.1177/1538574421993317] [Reference Citation Analysis]
184 Adegbola A, Behrendt CA, Zyriax BC, Windler E, Kreutzburg T. The impact of nutrition on the development and progression of peripheral artery disease: A systematic review. Clin Nutr 2021;41:49-70. [PMID: 34864455 DOI: 10.1016/j.clnu.2021.11.005] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
185 Bork CS, Lasota AN, Lundbye-Christensen S, Jakobsen MU, Tjønneland A, Calder PC, Schmidt EB, Overvad K. Intake of α-linolenic acid is not consistently associated with a lower risk of peripheral artery disease: results from a Danish cohort study. Br J Nutr 2019;122:86-92. [PMID: 31006418 DOI: 10.1017/S0007114519000874] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
186 Rashdan NA, Shrestha B, Pattillo CB. S-glutathionylation, friend or foe in cardiovascular health and disease. Redox Biol 2020;37:101693. [PMID: 32912836 DOI: 10.1016/j.redox.2020.101693] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
187 Clemens RK, Hunjadi M, Ritsch A, Rohrer L, Meier TO, Amann-Vesti B, von Eckardstein A, Annema W. Cholesterol Efflux Capacity Associates with the Ankle-Brachial Index but Not All-Cause Mortality in Patients with Peripheral Artery Disease. Diagnostics (Basel) 2021;11:1407. [PMID: 34441341 DOI: 10.3390/diagnostics11081407] [Reference Citation Analysis]
188 Trunfio R, Deslarzes-Dubuis C, Buso G, Fresa M, Brusa J, Stefanescu A, Zellweger M, Corpataux JM, Deglise S, Mazzolai L. The effects of COVID-19 pandemic on patients with lower extremity peripheral arterial disease: A near miss disaster. Ann Vasc Surg 2021:S0890-5096(21)00500-8. [PMID: 34411672 DOI: 10.1016/j.avsg.2021.07.006] [Reference Citation Analysis]
189 Chan C, Sounderajah V, Normahani P, Acharya A, Markar SR, Darzi A, Bicknell C, Riga C. Wearable Activity Monitors in Home Based Exercise Therapy for Patients with Intermittent Claudication: A Systematic Review. Eur J Vasc Endovasc Surg 2021;61:676-87. [PMID: 33451865 DOI: 10.1016/j.ejvs.2020.11.044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
190 Wun K, Theriault BR, Pierre JF, Chen EB, Leone VA, Harris KG, Xiong L, Jiang Q, Spedale M, Eskandari OM, Chang EB, Ho KJ. Microbiota control acute arterial inflammation and neointimal hyperplasia development after arterial injury. PLoS One 2018;13:e0208426. [PMID: 30521585 DOI: 10.1371/journal.pone.0208426] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
191 Anand SS, Hiatt W, Dyal L, Bauersachs R, Berkowitz SD, Branch KRH, Debus S, Fox KAA, Liang Y, Muehlhofer E, Nehler M, Haskell LP, Patel M, Szarek M, Yusuf S, Eikelboom J, Bonaca MP. Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials. Eur J Prev Cardiol 2021:zwab128. [PMID: 34463737 DOI: 10.1093/eurjpc/zwab128] [Reference Citation Analysis]
192 Krishnan P, Tarricone A, Chen S, Sharma S. The role of directional atherectomy in critical-limb ischemia. Ther Adv Cardiovasc Dis 2021;135:17539447211046953. [PMID: 34796770 DOI: 10.1177/17539447211046953] [Reference Citation Analysis]
193 Weissler EH, Zhang J, Lippmann S, Rusincovitch S, Henao R, Jones WS. Use of Natural Language Processing to Improve Identification of Patients With Peripheral Artery Disease. Circ Cardiovasc Interv 2020;13:e009447. [PMID: 33040585 DOI: 10.1161/CIRCINTERVENTIONS.120.009447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
194 Chaudhry AP, Afzal N, Abidian MM, Mallipeddi VP, Elayavilli RK, Scott CG, Kullo IJ, Wennberg PW, Pankratz JJ, Liu H, Chaudhry R, Arruda-Olson AM. Innovative Informatics Approaches for Peripheral Artery Disease: Current State and Provider Survey of Strategies for Improving Guideline-Based Care. Mayo Clin Proc Innov Qual Outcomes 2018;2:129-36. [PMID: 30035252 DOI: 10.1016/j.mayocpiqo.2018.02.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
195 Johnson LL, Johnson J, Ober R, Holland A, Zhang G, Backer M, Backer J, Ali Z, Tekabe Y. Novel Receptor for Advanced Glycation End Products-Blocking Antibody to Treat Diabetic Peripheral Artery Disease. J Am Heart Assoc 2021;10:e016696. [PMID: 33327730 DOI: 10.1161/JAHA.120.016696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
196 Sandberg A, Cider Å, Jivegård L, Nordanstig J, Wittboldt S, Bäck M. Test-retest reliability, agreement, and minimal detectable change in the 6-minute walk test in patients with intermittent claudication. J Vasc Surg 2020;71:197-203. [PMID: 31147129 DOI: 10.1016/j.jvs.2019.02.056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
197 Fan W, Zhang R, Han D, Jiang Z, Li S, Zhang J, Li Y, Wang Y, Cao F. Reduced Sirtuin1 signalling exacerbates diabetic mice hindlimb ischaemia injury and inhibits the protective effect of a liver X receptor agonist. J Cell Mol Med 2020;24:5476-90. [PMID: 32286000 DOI: 10.1111/jcmm.15201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
198 Provance JB, Spertus JA, Jones PG, Hoffman MA, Bunte MC, Vogel TR, Mena-Hurtado C, Smolderen KG. Variability in 30-day major amputation rates following endovascular peripheral vascular intervention for critical limb ischemia. Vasc Med 2022;:1358863X221098097. [PMID: 35603755 DOI: 10.1177/1358863X221098097] [Reference Citation Analysis]
199 Felício JS, de Melo FTC, Vieira GM, de Aquino VT, de Souza Parente F, da Silva WM, Said NM, da Silva ER, de Souza ACCB, de Oliveira MCNI, de Lemos GN, de Souza ÍJA, de Alcântara AL, de Moraes LV, Abrahão Neto JF, de Queiroz NNM, Mourão NAL, Piani PPF, Oliveira dos Reis MDS, Felício KM. Peripheral arterial disease progression and ankle brachial index: a cohort study with newly diagnosed patients with type 2 diabetes. BMC Cardiovasc Disord 2022;22. [DOI: 10.1186/s12872-022-02722-6] [Reference Citation Analysis]
200 Urriza Rodriguez D, Howard DP. Saving lives, saving limbs: tackling the global pandemic of peripheral arterial disease. Ital J Vasc Endovasc Surg 2019;26. [DOI: 10.23736/s1824-4777.19.01418-9] [Reference Citation Analysis]
201 Huang S, Sun H, Yu J, Shi H, Ren L, He Y, Zhang M, Peng H, Guo H. The Interaction Between Self-Reported Sleep Duration and Physical Activity on Peripheral Artery Disease in Chinese Adults: A Cross-Sectional Analysis in the Tianning Cohort Study. Risk Manag Healthc Policy 2021;14:4063-72. [PMID: 34616193 DOI: 10.2147/RMHP.S332098] [Reference Citation Analysis]
202 Semporé WY, Chao De La Barca JM, Hersant J, Ouédraogo N, Yaméogo TM, Henni S, Reynier P, Abraham P. Exercise-Induced Plasma Metabolomic Profiles in Patients With Peripheral Arterial Disease. Front Physiol 2021;12:758085. [PMID: 34867463 DOI: 10.3389/fphys.2021.758085] [Reference Citation Analysis]
203 Ceyhun G, Engin MÇ. The Monocyte/High Density Lipoprotein Cholesterol Ratio (MHR) as an Indicator of the Need for Amputation in Patients With Peripheral Artery Disease Developing Critical Limb Ischemia. Angiology 2021;72:268-73. [PMID: 33108889 DOI: 10.1177/0003319720965808] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
204 Vogel B, Acevedo M, Appelman Y, Bairey Merz CN, Chieffo A, Figtree GA, Guerrero M, Kunadian V, Lam CSP, Maas AHEM, Mihailidou AS, Olszanecka A, Poole JE, Saldarriaga C, Saw J, Zühlke L, Mehran R. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet 2021;397:2385-438. [PMID: 34010613 DOI: 10.1016/S0140-6736(21)00684-X] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 10.0] [Reference Citation Analysis]
205 Kanegusuku H, Cucato GG, Domiciano RM, Longano P, Puech-Leao P, Wolosker N, Ritti-Dias RM, Correia MA. Impact of obesity on walking capacity and cardiovascular parameters in patients with peripheral artery disease: A cross-sectional study. J Vasc Nurs 2020;38:66-71. [PMID: 32534655 DOI: 10.1016/j.jvn.2020.02.004] [Reference Citation Analysis]
206 Stock JK. Novel insights into lipoprotein(a): News from Atherosclerosis. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.02.003] [Reference Citation Analysis]
207 Xing J, Li J. TRPA1 Function in Skeletal Muscle Sensory Neurons Following Femoral Artery Occlusion. Cell Physiol Biochem 2017;42:2307-17. [PMID: 28848196 DOI: 10.1159/000480003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
208 Chen Y, Li X, Zhao L, Wu G. Association between sleep-disordered breathing and lower extremity artery disease: a meta-analysis. Sleep Breath 2021;25:227-36. [DOI: 10.1007/s11325-020-02096-z] [Reference Citation Analysis]
209 Wieczór R, Kulwas A, Rość D. Implications of Hemostasis Disorders in Patients with Critical Limb Ischemia-An In-Depth Comparison of Selected Factors. J Clin Med 2020;9:E659. [PMID: 32121363 DOI: 10.3390/jcm9030659] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
210 Janas A, Milewski K, Buszman P, Kolarczyk-Haczyk A, Trendel W, Pruski M, Wojakowski W, Buszman P, Kiesz RS. Comparison of long-term outcomes after directional versus rotational atherectomy in peripheral artery disease. Postepy Kardiol Interwencyjnej 2020;16:76-81. [PMID: 32368239 DOI: 10.5114/aic.2020.93914] [Reference Citation Analysis]
211 Fu J, Zou J, Chen C, Li H, Wang L, Zhou Y. Hydrogen molecules (H2) improve perfusion recovery via antioxidant effects in experimental peripheral arterial disease. Mol Med Rep 2018;18:5009-15. [PMID: 30320393 DOI: 10.3892/mmr.2018.9546] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
212 Stock JK. Joint statement from the European Atherosclerosis Society and European Society of Vascular Medicine focuses on patients with peripheral arterial disease. Atherosclerosis 2022;340:48-50. [PMID: 34863531 DOI: 10.1016/j.atherosclerosis.2021.11.015] [Reference Citation Analysis]
213 Lin E, Nguyen CH, Thomas SG. Completion and adherence rates to exercise interventions in intermittent claudication: Traditional exercise vs alternative exercise - a systematic review. Eur J Prev Cardiol. 2019;26:1625-1633. [PMID: 31216860 DOI: 10.1177/2047487319846997] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
214 Hughes WE, Treichler DP, Ueda K, Bock JM, Casey DP. Sodium nitrate supplementation improves blood pressure reactivity in patients with peripheral artery disease. Nutrition, Metabolism and Cardiovascular Diseases 2021. [DOI: 10.1016/j.numecd.2021.12.002] [Reference Citation Analysis]
215 Golledge J, Ward NC, Watts GF. Lipid management in people with peripheral artery disease. Curr Opin Lipidol 2019;30:470-6. [PMID: 31577608 DOI: 10.1097/MOL.0000000000000638] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
216 Khodayari S, Khodayari H, Ebrahimi-barough S, Khanmohammadi M, Islam MS, Vesovic M, Goodarzi A, Mahmoodzadeh H, Nayernia K, Aghdami N, Ai J. Stem Cell Therapy in Limb Ischemia: State-of-Art, Perspective, and Possible Impacts of Endometrial-Derived Stem Cells. Front Cell Dev Biol 2022;10:834754. [DOI: 10.3389/fcell.2022.834754] [Reference Citation Analysis]
217 Perl L, Bental T, Vaknin-Assa H, Assali A, Codner P, Talmor-Barkan Y, Greenberg G, Samara A, Witberg G, Orvin K, Kornowski R. Independent Impact of Peripheral Artery Disease on Percutaneous Coronary Intervention. J Am Heart Assoc 2020;9:e017655. [PMID: 33283578 DOI: 10.1161/JAHA.120.017655] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
218 Dai L, Zhou Q, Zhou H, Zhang H, Cheng P, Ding M, Xu X, Zhang X. Deep learning-based classification of lower extremity arterial stenosis in computed tomography angiography. Eur J Radiol 2021;136:109528. [PMID: 33450660 DOI: 10.1016/j.ejrad.2021.109528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Jamee A, Aboyans V, Magne J, Elhendy M, Marie Preux P, Lacroix P. Epidemiology of peripheral artery disease in Palestine. Vasa 2020;49:323-9. [PMID: 32452724 DOI: 10.1024/0301-1526/a000871] [Reference Citation Analysis]
220 Peñín-Grandes S, Santos-Lozano A, Pinto-Fraga J, de la Fuente Gómez M, Del Río Solá ML, Martín-Hernández J. Moderate Intensity Functional Training as Adjuvant Treatment in Patients With Peripheral Arterial Disease: A Case Report. Ann Vasc Surg 2021:S0890-5096(21)00700-7. [PMID: 34648862 DOI: 10.1016/j.avsg.2021.07.038] [Reference Citation Analysis]
221 Tsioufis C, Andrikou I, Siasos G, Filis K, Tousoulis D. Anti-hypertensive treatment in peripheral artery disease. Current Opinion in Pharmacology 2018;39:35-42. [DOI: 10.1016/j.coph.2018.01.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
222 Chen L, Jin Y, Wang N, Yuan M, Lin T, Lu W, Wang T. Trimethylamine N-oxide impairs perfusion recovery after hindlimb ischemia. Biochem Biophys Res Commun 2020;530:95-9. [PMID: 32828321 DOI: 10.1016/j.bbrc.2020.06.093] [Reference Citation Analysis]
223 Mao Y, Huang Y, Yu H, Xu P, Yu G, Yu J, Zhan Y. Incidence of Peripheral Arterial Disease and Its Association with Pulse Pressure: A Prospective Cohort Study. Front Endocrinol (Lausanne) 2017;8:333. [PMID: 29225591 DOI: 10.3389/fendo.2017.00333] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
224 Colantonio LD, Hubbard D, Monda KL, Mues KE, Huang L, Dai Y, Jackson EA, Brown TM, Rosenson RS, Woodward M, Muntner P, Farkouh ME. Atherosclerotic Risk and Statin Use Among Patients With Peripheral Artery Disease. Journal of the American College of Cardiology 2020;76:251-64. [DOI: 10.1016/j.jacc.2020.05.048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
225 Li YH, Sheu WH, Lee IT. Use of the ankle-brachial index combined with the percentage of mean arterial pressure at the ankle to improve prediction of all-cause mortality in type 2 diabetes mellitus: an observational study. Cardiovasc Diabetol 2020;19:173. [PMID: 33036608 DOI: 10.1186/s12933-020-01149-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
226 Monroe JC, Lin C, Perkins SM, Han Y, Wong BJ, Motaganahalli RL, Roseguini BT. Leg heat therapy improves perceived physical function but does not enhance walking capacity or vascular function in patients with peripheral artery disease. J Appl Physiol (1985) 2020;129:1279-89. [PMID: 33002377 DOI: 10.1152/japplphysiol.00277.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
227 Hu H, Li L, Yu T, Li Y, Tang Y. Interleukin-22 receptor 1 upregulation and activation in hypoxic endothelial cells improves perfusion recovery in experimental peripheral arterial disease. Biochem Biophys Res Commun 2018;505:60-6. [PMID: 30236983 DOI: 10.1016/j.bbrc.2018.08.163] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
228 Mantella LE, Liblik K, Johri AM. Vascular imaging of atherosclerosis: Strengths and weaknesses. Atherosclerosis 2021;319:42-50. [PMID: 33476943 DOI: 10.1016/j.atherosclerosis.2020.12.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
229 Wang Y, Feng T, Zhou H, Lu K, Bai Y, Zhang P. Vitamin D Deficiency May Not Be an Independent Risk Factor for Peripheral Arterial Disease in Middle-Aged and Elderly Patients with Type 2 Diabetes in China. Dis Markers 2020;2020:8854717. [PMID: 33299499 DOI: 10.1155/2020/8854717] [Reference Citation Analysis]
230 Freisinger E, Koeppe J, Gerss J, Goerlich D, Malyar NM, Marschall U, Faldum A, Reinecke H. Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis. Eur Heart J 2020;41:3732-9. [PMID: 31593987 DOI: 10.1093/eurheartj/ehz698] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 61.0] [Reference Citation Analysis]
231 Peñín-grandes S, Martín-hernández J, Valenzuela PL, López-ortiz S, Pinto-fraga J, Solá LDR, Emanuele E, Lista S, Lucia A, Santos-lozano A. Exercise and the hallmarks of peripheral arterial disease. Atherosclerosis 2022;350:41-50. [DOI: 10.1016/j.atherosclerosis.2022.04.025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Rha SW, Choi SH, Kim DI, Jeon DW, Lee JH, Hong KS, Cha TJ, Cho JH, Lee SK, Park YH, Park WJ, Kim HJ, Kim YJ, Lee J, Choi D; PADO research investigators. Medical Resource Consumption and Quality of Life in Peripheral Arterial Disease in Korea: PAD Outcomes (PADO) Research. Korean Circ J 2018;48:813-25. [PMID: 30088358 DOI: 10.4070/kcj.2017.0340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
233 Hess CN, Bonaca MP. Risk of remnants and remnant risk in peripheral artery disease. Eur Heart J 2021:ehab815. [PMID: 34888625 DOI: 10.1093/eurheartj/ehab815] [Reference Citation Analysis]
234 Barrios V, Beato P, Brotons C, Campuzano R, Merino-Torres JF, Mostaza JM, Plana N, Rubio JA, Comellas M; CREVASP working group. Comprehensive management of risk factors in peripheral vascular disease. Expert consensus. Rev Clin Esp (Barc) 2021:S2254-8874(21)00110-7. [PMID: 34217671 DOI: 10.1016/j.rceng.2020.11.011] [Reference Citation Analysis]
235 Lee DW, Cavender MA. Guidelines for Peripheral Vascular Disease: Where Is the Evidence? Circ Cardiovasc Interv 2019;12:e007561. [PMID: 30608871 DOI: 10.1161/CIRCINTERVENTIONS.118.007561] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
236 Ang HY, Xiong GM, Chaw SY, Phua JL, Ng JCK, Wong PEH, Venkatraman S, Chong TT, Huang Y. Adventitial injection delivery of nano-encapsulated sirolimus (Nanolimus) to injury-induced porcine femoral vessels to reduce luminal restenosis. J Control Release 2020;319:15-24. [PMID: 31863795 DOI: 10.1016/j.jconrel.2019.12.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
237 Pereira K. Treatment Strategies for the Claudicant. Semin Intervent Radiol. 2018;35:435-442. [PMID: 30728659 DOI: 10.1055/s-0038-1676322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
238 Kosmas CE, Silverio D, Sourlas A, Peralta R, Montan PD, Guzman E, Garcia MJ. Role of lipoprotein (a) in peripheral arterial disease. Ann Transl Med 2019;7:S242. [PMID: 31656821 DOI: 10.21037/atm.2019.08.77] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
239 Saenz-pipaon G, Ravassa S, Larsen KL, Martinez-aguilar E, Orbe J, Rodriguez JA, Fernandez-alonso L, Gonzalez A, Martín-ventura JL, Paramo JA, Lindholt JS, Roncal C. Lipocalin-2 and Calprotectin Potential Prognosis Biomarkers in Peripheral Arterial Disease. European Journal of Vascular and Endovascular Surgery 2022. [DOI: 10.1016/j.ejvs.2022.01.012] [Reference Citation Analysis]
240 Zuin M, Rigatelli G, Bilato MJ, Bilato C, Roncon L. Prevalence of pre-existing peripheral artery disease in COVID-19 patients and relative mortality risk: Systematic review and meta-analysis. Vascular 2022;:17085381221100380. [PMID: 35593210 DOI: 10.1177/17085381221100380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
241 Aitken SJ, Randall DA, Noguchi N, Blyth FM, Naganathan V. Multiple Peri-Operative Complications are Associated with Reduced Long Term Amputation Free Survival Following Revascularisation for Lower Limb Peripheral Artery Disease: A Population Based Linked Data Study. European Journal of Vascular and Endovascular Surgery 2020;59:437-45. [DOI: 10.1016/j.ejvs.2019.11.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
242 Kumar A, Bano S, Bhurgri U, Kumar J, Ali A, Dembra S, Kumar L, Shahid S, Khalid D, Rizwan A. Peripheral Artery Disease as a Predictor of Coronary Artery Disease in Patients Undergoing Coronary Angiography. Cureus 2021;13:e15094. [PMID: 34159004 DOI: 10.7759/cureus.15094] [Reference Citation Analysis]
243 Gulaĭ IS, Snegirev AI, Denisova NP, Dmitriev AB. [Chronic spinal stimulation in treatment of lower limb critical ischaemia syndrome]. Angiol Sosud Khir 2021;27:128-35. [PMID: 33825739 DOI: 10.33529/ANGIO2020413] [Reference Citation Analysis]
244 Schmidt A, Schreve MA, Huizing E, Del Giudice C, Branzan D, Ünlü Ç, Varcoe RL, Ferraresi R, Kum S. Midterm Outcomes of Percutaneous Deep Venous Arterialization With a Dedicated System for Patients With No-Option Chronic Limb-Threatening Ischemia: The ALPS Multicenter Study. J Endovasc Ther 2020;27:658-65. [PMID: 32419597 DOI: 10.1177/1526602820922179] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
245 Feng H, Chen X, Guo X, Zhang Z, Zhang Z, Liu B, Lian L. Comparison of efficacy and safety of drug-eluting versus uncoated balloon angioplasty for femoropopliteal arterial occlusive disease: a meta-analysis. BMC Cardiovasc Disord 2020;20:395. [PMID: 32867681 DOI: 10.1186/s12872-020-01667-y] [Reference Citation Analysis]
246 Russell KS, Yates DP, Kramer CM, Feller A, Mahling P, Colin L, Clough T, Wang T, LaPerna L, Patel A, Lawall H, Shennak MM, Fulmer J, Nikol S, Smith WB, Müller OJ, Ratchford EV, Basson CT. A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease. Vasc Med 2019;24:414-21. [PMID: 31277561 DOI: 10.1177/1358863X19859072] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
247 Kuzawa CW, Barrett TM, Borja JB, Lee NR, Aquino CT, Adair LS, McDade TW. Ankle brachial index (ABI) in a cohort of older women in the Philippines: Prevalence of peripheral artery disease and predictors of ABI. Am J Hum Biol 2019;31:e23237. [PMID: 30950564 DOI: 10.1002/ajhb.23237] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
248 Song P, Rudan D, Zhu Y, Fowkes FJI, Rahimi K, Fowkes FGR, Rudan I. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7:e1020-e1030. [PMID: 31303293 DOI: 10.1016/s2214-109x(19)30255-4] [Cited by in Crossref: 154] [Cited by in F6Publishing: 55] [Article Influence: 77.0] [Reference Citation Analysis]
249 Cedarbaum E, Ma Y, Scherzer R, Price JC, Adimora AA, Bamman M, Cohen M, Fischl MA, Matsushita K, Ofotokun I, Plankey M, Seaberg EC, Yin MT, Grunfeld C, Vartanian S, Sharma A, Tien PC. Contributions of HIV, hepatitis C virus, and traditional vascular risk factors to peripheral artery disease in women. AIDS 2019;33:2025-33. [PMID: 31335806 DOI: 10.1097/QAD.0000000000002319] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
250 Xin H, Li Y, Guan X, Wang Y, Liu J, Liu X, Wang J, Niu L, Li J. Impact of prior endovascular interventions on outcomes of lower limb bypass surgery: A systematic review and meta-analysis. Exp Ther Med 2020;20:259. [PMID: 33209124 DOI: 10.3892/etm.2020.9389] [Reference Citation Analysis]
251 Serra R, Bracale UM, Barbetta A, Ielapi N, Licastro N, Gallo A, Fregola S, Turchino D, Gasbarro V, Mastroroberto P, de Franciscis S. PredyCLU: A prediction system for chronic leg ulcers based on fuzzy logic; part II-Exploring the arterial side. Int Wound J 2020;17:987-91. [PMID: 32285613 DOI: 10.1111/iwj.13360] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
252 Nwadozi E, Rudnicki M, De Ciantis M, Milkovich S, Pulbere A, Roudier E, Birot O, Gustafsson T, Ellis CG, Haas TL. High-fat diet pre-conditioning improves microvascular remodelling during regeneration of ischaemic mouse skeletal muscle. Acta Physiol (Oxf) 2020;229:e13449. [PMID: 32012450 DOI: 10.1111/apha.13449] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
253 Aboyans V, Desormais I. Can we accurately measure the ankle-brachial index in patients with atrial fibrillation? Hypertens Res 2018;41:487-8. [PMID: 29720675 DOI: 10.1038/s41440-018-0039-z] [Reference Citation Analysis]
254 Li Z, Englund EK, Langham MC, Feng J, Jia K, Floyd TF, Yodh AG, Baker WB. Exercise Training Increases Resting Calf Muscle Oxygen Metabolism in Patients with Peripheral Artery Disease. Metabolites 2021;11:814. [PMID: 34940572 DOI: 10.3390/metabo11120814] [Reference Citation Analysis]
255 Zheng Q, Dong P, Li Z, Lv Y, An M, Gu L. Braided composite stent for peripheral vascular applications. Nanotechnology Reviews 2020;9:1137-46. [DOI: 10.1515/ntrev-2020-0056] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
256 Tang T, Zhang M, Li W, Hu N, Du X, Ran F, Li X. Oral Anticoagulant and Antiplatelet Therapy for Peripheral Arterial Disease: A Meta-analysis of Randomized Controlled Trials. Clin Appl Thromb Hemost 2021;27:1076029621996810. [PMID: 33783251 DOI: 10.1177/1076029621996810] [Reference Citation Analysis]
257 Rammos C, Steinmetz M, Lortz J, Mahabadi AA, Petrikhovich O, Kirsch K, Hering R, Schulz M, Rassaf T. Peripheral artery disease in Germany (2009-2018): Prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy - A population-based study. Lancet Reg Health Eur 2021;5:100113. [PMID: 34557822 DOI: 10.1016/j.lanepe.2021.100113] [Reference Citation Analysis]
258 Hernandez H, Myers SA, Schieber M, Ha DM, Baker S, Koutakis P, Kim KS, Mietus C, Casale GP, Pipinos II. Quantification of Daily Physical Activity and Sedentary Behavior of Claudicating Patients. Ann Vasc Surg 2019;55:112-21. [PMID: 30114505 DOI: 10.1016/j.avsg.2018.06.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
259 Mustapha J, Gray W, Martinsen BJ, Bolduan RW, Adams GL, Ansel G, Jaff MR. One-Year Results of the LIBERTY 360 Study: Evaluation of Acute and Midterm Clinical Outcomes of Peripheral Endovascular Device Interventions. J Endovasc Ther 2019;26:143-54. [PMID: 30722718 DOI: 10.1177/1526602819827295] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
260 Sunner SS, Welsh RC, Bainey KR. Medical Management of Peripheral Arterial Disease: Deciphering the Intricacies of Therapeutic Options. CJC Open 2021;3:936-49. [PMID: 34401701 DOI: 10.1016/j.cjco.2021.03.005] [Reference Citation Analysis]
261 Kim K, Anderson EM, Scali ST, Ryan TE. Skeletal Muscle Mitochondrial Dysfunction and Oxidative Stress in Peripheral Arterial Disease: A Unifying Mechanism and Therapeutic Target. Antioxidants (Basel) 2020;9:E1304. [PMID: 33353218 DOI: 10.3390/antiox9121304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
262 Alsuwailem B, Zamzam A, Syed MH, Greco E, Wheatcroft M, de Mestral C, Al-Omran M, Harlock J, Eikelboom J, Singh KK, Abdin R, Qadura M. Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease. PLoS One 2021;16:e0253792. [PMID: 34288948 DOI: 10.1371/journal.pone.0253792] [Reference Citation Analysis]
263 Chen L, Zhang L, Fang Z, Li C, Yang Y, You X, Song M, Coffie J, Zhang L, Gao X, Wang H. Naoxintong restores collateral blood flow in a murine model of hindlimb ischemia through PPARδ-dependent mechanism. Journal of Ethnopharmacology 2018;227:121-30. [DOI: 10.1016/j.jep.2018.08.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
264 Bertomeu-Gonzalez V, Moreno-Arribas J, Esteve-Pastor MA, Roldán-Rabadán I, Muñiz J, Otero García D, Ruiz-Ortiz M, Cequier Á, Bertomeu-Martínez V, Badimón L, Anguita M, Lip GYH, Marín F; FANTASIIA Study Investigators. Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry. Eur J Clin Invest 2021;51:e13431. [PMID: 33065765 DOI: 10.1111/eci.13431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
265 Zhang J, Wang Q, Rao G, Qiu J, He R. Curcumin improves perfusion recovery in experimental peripheral arterial disease by upregulating microRNA-93 expression. Exp Ther Med 2019;17:798-802. [PMID: 30651865 DOI: 10.3892/etm.2018.7000] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
266 Sedgwick CE, Growcott C, Akhtar S, Parker D, Pettersen EM, Hashmi F, Williams AE. Patient and clinician experiences and opinions of the use of a novel home use medical device in the treatment of peripheral vascular disease - a qualitative study. J Foot Ankle Res 2021;14:61. [PMID: 34861883 DOI: 10.1186/s13047-021-00496-2] [Reference Citation Analysis]
267 Wang D, Zhang Q, Wang A, Wu S, Zhao X. Ideal Cardiovascular Health Metrics on the New Occurrence of Peripheral Artery Disease: A Prospective Cohort Study in Northern China. Sci Rep 2020;10:9660. [PMID: 32541812 DOI: 10.1038/s41598-020-66578-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
268 Chowdhury M, Secemsky EA. Atherectomy vs Other Modalities for Treatment During Peripheral Vascular Intervention. Curr Cardiol Rep 2022. [PMID: 35536534 DOI: 10.1007/s11886-022-01709-1] [Reference Citation Analysis]
269 Parmenter BH, Croft KD, Hodgson JM, Dalgaard F, Bondonno CP, Lewis JR, Cassidy A, Scalbert A, Bondonno NP. An overview and update on the epidemiology of flavonoid intake and cardiovascular disease risk. Food Funct 2020;11:6777-806. [PMID: 32725042 DOI: 10.1039/d0fo01118e] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
270 Gonçalves-Martins G, Gil-Sala D, Tello-Díaz C, Tenezaca-Sari X, Marrero C, Puig T, Gayarre R, Fité J, Bellmunt-Montoya S. Prevalence of Peripheral Arterial Disease and Associated Vascular Risk Factors in 65-Years-Old People of Northern Barcelona. J Clin Med 2021;10:4467. [PMID: 34640483 DOI: 10.3390/jcm10194467] [Reference Citation Analysis]
271 Messiha D, Kleinhans M, Rammos C, Dissemond J, Rassaf T, Steinmetz M. A Case of Critical Essential Thrombocythemia Complicated by Severe Lower-Extremity Arterial Disease. Am J Case Rep 2021;22:e928340. [PMID: 33550325 DOI: 10.12659/AJCR.928340] [Reference Citation Analysis]